Isobutyraldehyde → 2-[4-(3-Methyl-1,2,4-oxadiazol-5-yl)phenyl]-6-(2-methylpropyl)-2,4,5,6,7,8-hexahydropyrazolo[3,4-d]azepine
반응식
[CH3:1][C:2]1[N:6]=[C:5]([C:7]2[CH:12]=[CH:11][C:10]([N:13]3[CH:22]=[C:21]4[C:15]([CH2:16][CH2:17][NH:18][CH2:19][CH2:20]4)=[N:14]3)=[CH:9][CH:8]=2)[O:4][N:3]=1.[CH3:23][CH:24]([CH3:27])[CH:25]=O.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>ClCCl.C(O)(=O)C.CO>[CH3:1][C:2]1[N:6]=[C:5]([C:7]2[CH:12]=[CH:11][C:10]([N:13]3[CH:22]=[C:21]4[C:15]([CH2:16][CH2:17][N:18]([CH2:23][CH:24]([CH3:27])[CH3:25])[CH2:19][CH2:20]4)=[N:14]3)=[CH:9][CH:8]=2)[O:4][N:3]=1참가 물질
반응물 3
생성물 1
시약·촉매·용매 3
실험 절차
To a solution of 2-[4-(3-methyl-1,2,4-oxadiazol-5-yl)phenyl]-2,4,5,6,7,8-hexahydropyrazolo[3,4-d]azepine (may be prepared as described in Description 35) (31 mg, 0.10 mmol) in dichloromethane (4 ml) was added 2-methylpropanal (30 mg, 0.42 mmol) and acetic acid (3 drops). The resulting mixture was stirred at room temperature, under argon, for 20 minutes. Sodium triacetoxyborohydride (89 mg, 0.42 mmol) was added and stirring continued overnight. The resulting crude mixture was diluted with methanol and then purified by SCX, eluting with methanol and then with 2M ammonia/methanol. The basic fractions were combined and solvent evaporated in vacuo. Crude product was purified further by column chromatography on silica gel, eluting with a mixture of 2M ammonia in methanol in dichloromethane (0-1%) to afford the title compound (E21). MS (ES+) m/e 352 [M+H]+.
후처리
- stirringstirring continued overnight
- custompurified by SCX
- washeluting with methanol
- customsolvent evaporated in vacuo
- customCrude product was purified further by column chromatography on silica gel
- washeluting with a mixture of 2M ammonia in methanol in dichloromethane (0-1%)
출처 및 근거
- ORD 기록
- ord-10adf602881b464ab6150bb91d6e528e
- 출처 데이터셋
- uspto-grants-2011_02
- 특허 번호
- US07888347B2
반응 노트
불러오는 중…